Price
561.65
+2.11%52W Range
Market Cap
₹1,821.92 Cr
Traded: ₹5.39 Cr (0.30%) 0.0x
Free Float: ₹686.50 Cr (0.79% of FF traded)
Volume · 60D trend
95.89 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Profit | +37.0% | -- | +18.0% | -- | +22.0% | Stable |
| ROE | -- | +9.0% | +9.0% | -- | -- | Stable |
| Return | -- | -- | +5.0% | -28.0% | -- | Decelerating |
| Sales | +35.0% | -- | +17.0% | -- | +10.0% | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 236 | 193 | 181 | 206 | 193 | 186 | 175 | 186 | 170 | 166 | 158 | 155 | 140 | 133 | 118 | 123 |
| Expenses | 178 | 138 | 135 | 147 | 142 | 133 | 129 | 137 | 128 | 123 | 121 | 124 | 108 | 99 | 89 | 92 |
| Operating Profit | 58 | 55 | 46 | 59 | 51 | 53 | 45 | 49 | 43 | 44 | 37 | 32 | 31 | 34 | 29 | 31 |
| OPM % | 25.0% | 28.0% | 26.0% | 29.0% | 27.0% | 28.0% | 26.0% | 27.0% | 25.0% | 26.0% | 24.0% | 20.0% | 22.0% | 26.0% | 25.0% | 25.0% |
| Other Income | 7 | 32 | 4 | 4 | 4 | 4 | 9 | 5 | 7 | 4 | 4 | 4 | 4 | 6 | 5 | 4 |
| Interest | 15 | 12 | 8 | 8 | 6 | 7 | 6 | 6 | 5 | 7 | 4 | 3 | 2 | 2 | 2 | 2 |
| Depreciation | 28 | 23 | 23 | 24 | 22 | 22 | 23 | 22 | 21 | 18 | 21 | 19 | 16 | 15 | 14 | 13 |
| Profit Before Tax | 22 | 52 | 20 | 32 | 27 | 29 | 25 | 25 | 23 | 23 | 16 | 13 | 18 | 24 | 18 | 20 |
| Tax % | 26.0% | 19.0% | 23.0% | 24.0% | 25.0% | 28.0% | 24.0% | 23.0% | 23.0% | 17.0% | 19.0% | 22.0% | 18.0% | 20.0% | 23.0% | 24.0% |
| Net Profit | 17 | 42 | 15 | 24 | 21 | 21 | 19 | 20 | 18 | 19 | 13 | 10 | 15 | 19 | 14 | 15 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 5.1 | 12.9 | 4.7 | 7.4 | 6.3 | 6.4 | 6.0 | 6.1 | 5.5 | 5.8 | 4.0 | 3.3 | 4.7 | 6.0 | 4.3 | 4.9 |
| Sales Growth (YoY) | 22.3% | 3.8% | 3.4% | 10.8% | 13.5% | 12.1% | 10.8% | 20.0% | 21.4% | 24.8% | 33.9% | 26.0% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 22.3% | 6.6% | -12.1% | 6.7% | 3.8% | 6.3% | -5.9% | 9.4% | 2.4% | 5.1% | 1.9% | 10.7% | 5.3% | 12.7% | -4.1% | -- |
| OP Growth (YoY) | 13.7% | 3.8% | 2.2% | 20.4% | 18.6% | 20.5% | 21.6% | 53.1% | 38.7% | 29.4% | 27.6% | 3.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | 5.5% | 19.6% | -22.0% | 15.7% | -3.8% | 17.8% | -8.2% | 14.0% | -2.3% | 18.9% | 15.6% | 3.2% | -8.8% | 17.2% | -6.5% | -- |
| Profit Growth (YoY) | -19.4% | 101.7% | -21.5% | 22.2% | 14.5% | 10.4% | 49.7% | 86.7% | 22.4% | -1.0% | -4.9% | -31.6% | 3.0% | 5.0% | -16.5% | 22.4% |
| EPS Growth (YoY) | -19.4% | 100.9% | -21.8% | 21.6% | 14.1% | 10.3% | 49.5% | 81.7% | 19.1% | -3.8% | -7.4% | -31.7% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -60.3% | 173.6% | -36.3% | 16.6% | -1.1% | 6.5% | -1.0% | 9.4% | -4.3% | 44.3% | 20.4% | -28.3% | -22.7% | 38.9% | -11.3% | -- |
| OP Margin | 24.6% | 28.5% | 25.4% | 28.6% | 26.4% | 28.5% | 25.7% | 26.3% | 25.3% | 26.5% | 23.4% | 20.6% | 22.1% | 25.6% | 24.6% | 25.2% |
| Net Margin | 7.2% | 21.8% | 8.3% | 11.7% | 10.9% | 11.3% | 10.9% | 10.8% | 10.6% | 11.4% | 8.2% | 6.5% | 10.7% | 14.3% | 11.9% | 12.2% |
| Material Cost % | 21.3% | 23.0% | 21.6% | 23.4% | 24.6% | 22.3% | 22.9% | 24.1% | 25.2% | 25.9% | 21.7% | 23.1% | 19.9% | 19.3% | 16.3% | 14.1% |
| Employee Cost % | 15.3% | 17.3% | 20.0% | 17.2% | 18.4% | 17.6% | 20.6% | 18.8% | 19.4% | 19.5% | 18.7% | 17.0% | 16.4% | 15.8% | 16.0% | 14.9% |
| P/S | 2.23 | 2.34 | 2.35 | 2.71 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 18.70 | 17.80 | 22.32 | 24.33 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.86 | 1.84 | 1.95 | 2.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015
Transcript of Earnings Call for quarter ended June 30, 2026
Newspaper Advertisement for Postal Ballot
Notice of Postal Ballot for Preferential Issue of Warrants
Newspaper advertisement pertaining to the Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30, 2026
Earnings Call Recording for Quarter ended June 30, 2026
Investor Presentation
Press Release
Fixation of Book Closure Date for Dividend
Fixation of Record Date for Dividend
Outcome of Board Meeting held on August 13, 2026
Financial Results for Quarter ended June 30, 2026
Intimation of 16th AGM
Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the unaudited standalone ....
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for signing of agreement with Authority
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations,2018
Disclosure of Scrutinizers Report along with Voting Results
Disclosure of Scrutinizers Report along with Voting Results
Credit Rating
Intimation for closure of Trading Window
Notice of Postal Ballot
Earnings call Transcript for the quarter and year ended March 31, 2026
Newspaper publication for the quarter and year ended March 31, 2026
Earnings call Recording for the quarter ended March 31, 2026
Outcome of Board Meeting held on May 25, 2026
Recommendation of Final Dividend
Financial Results for Quarter and Year ended on March 31, 2026
Annual Secretarial Compliance Report for the year ended March 31, 2026
Appointment/Re-appointment of Auditors
Press Release on the audited (standalone and consolidated) Financial Results for the quarter and year ended March 31, 2026
Investor Presentation for quarter and year ended March 31, 2026
Investor Call Updates - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Investor Call Updates - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve standalone and consolidated ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Outcome of Board Meeting held on April 17, 2026.
Outcome of Board Meeting held on April 17, 2026.
Outcome of Board Meeting held on April 17, 2026.
Disclosure of Voting Results along with Scrutinizer''s Report.
Disclosure of Voting Results along with Scrutinizer''s Report for Postal Ballot.
Submission of Confirmation Certificate in the matter of 74(5) of SEBI (Depositories and Participants) Regulation 2018 for quarter ended March 31, 2026.
Intimation of resignation of Senior Management Personnel.
Intimation of Closure of Trading Window for quarter and year ending on March 31, 2026.
Newspaper advertisement for Notice of Postal Ballot.
Intimation of Postal Ballot Notice for the re-appointment of Mr. Rajendra Khivraj Mutha as Whole-time Director of the Company designated as Executive Chairman.
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Analyst / Institutional Investor Meeting scheduled on February 27, 2026.
Allotment of Non-convertible Debentures.
Re-appointment of Mr. Rajendra Mutha, Whole-time Director and Chairman designated as Executive Chairman subject to Shareholder''s approval with effect from April 26, 2026.
Credit Ratings
6Concalls
23Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Oct 2024
31 Oct 2024Aug 2024
31 Aug 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Jun 2022
30 Jun 2022Mar 2022
31 Mar 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Oct 2021
31 Oct 2021Held by ETFs
1 ETFs hold krsnaa · sorted by weight
Held by Mutual Funds
4 schemes hold krsnaa · sorted by weight